Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology

Annals of the New York Academy of Sciences

Volumn 1220, Issue 1, 2011, Pages 6-15

  Córdoba Chacón, José ^a   Gahete, Manuel D ^a   Durán Prado, Mario ^a   Luque, Raul M ^a   Castaño, Justo P ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Cortistatin; Pituitary tumors; Somatostatin; Truncated receptors

Indexed keywords

CORTISTATIN; G PROTEIN COUPLED RECEPTOR; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 5;

ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN INTERACTION; TUMOR GROWTH;

RATTUS; SUIDAE;

EID: 79952456492     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.05985.x     Document Type: Article

References (71)

1. Moller, L.N., C.E. Stidsen, B. Hartmann & J.J. Holst 2003. Somatostatin receptors. Biochim. Biophys. Acta 1616: 1-84.
2. Siehler, S., C. Nunn, J. Hannon, et al 2008. Pharmacological profile of somatostatin and cortistatin receptors. Mol. Cell Endocrinol. 286: 26-34.
3. Brazeau, P., W. Vale, R. Burgus, et al 1973. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79.
4. de Lecea, L., J.R. Criado, O. Prospero-Garcia, et al 1996. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381: 242-245.
5. Tostivint, H., I. Lihrmann, C. Bucharles, et al 1996. Occurrence of two somatostatin variants in the frog brain: characterization of the cDNAs, distribution of the mRNAs, and receptor-binding affinities of the peptides. Proc. Natl. Acad. Sci. U.S.A. 93: 12605-12610.
6. Fukusumi, S., C. Kitada, S. Takekawa, et al 1997. Identification and characterization of a novel human cortistatin-like peptide. Biochem. Biophys. Res. Commun. 232: 157-163.
7. Patel, Y.C. 1999. Somatostatin and its receptor family. Front Neuroendocrinol. 20: 157-198.
8. Viollet, C., G. Lepousez, C. Loudes, et al 2008. Somatostatinergic systems in brain: networks and functions. Mol. Cell Endocrinol. 286: 75-87.
9. de Lecea, L. 2008. Cortistatin-functions in the central nervous system. Mol. Cell Endocrinol. 286: 88-95.
10. de Lecea, L. & J.P. Castaño 2006. Cortistatin: not just another somatostatin analog. Nat. Clin. Pract. Endocrinol. Metab. 2: 356-357.
11. Gonzalez-Rey, E. & M. Delgado 2008. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders. Mol. Cell Endocrinol. 286: 135-140.
12. Broglio, F., S. Grottoli, E. Arvat & E. Ghigo 2008. Endocrine actions of cortistatin: in vivo studies. Mol. Cell Endocrinol. 286: 123-127.
13. Gahete, M.D., M. Duran-Prado, R.M. Luque, et al 2008. Are somatostatin and cortistatin two siblings in regulating endocrine secretions?In vitro work ahead. Mol. Cell Endocrinol. 286: 128-134.
14. Luque, R.M. & R.D. Kineman 2007. Gender-dependent role of endogenous somatostatin in regulating growth hormone-axis function in mice. Endocrinology 148: 5998-6006.
15. Low, M.J., V. Otero-Corchon, A.F. Parlow, et al 2001. Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J. Clin. Invest. 107: 1571-1580.
16. Ramirez, J.L., R. Mouchantaf, U. Kumar, et al 2002. Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. Mol. Endocrinol. 16: 1951-1963.
17. Zeyda, T., N. Diehl, R. Paylor, et al 2001. Impairment in motor learning of somatostatin null mutant mice. Brain Res. 906: 107-114.
18. Robas, N., E. Mead & M. Fidock 2003. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J. Biol. Chem. 278: 44400-44404.
19. Deghenghi, R., M. Papotti, E. Ghigo & G. Muccioli 2001. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J. Endocrinol. Invest. 24: RC1-RC3.
20. Patel, Y.C., R. Panetta, E. Escher, et al 1994. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J. Biol. Chem. 269: 1506-1509.
21. Tallent, M., M.A. Dichter & T. Reisine 1996. Evidence that a novel somatostatin receptor couples to an inward rectifier potassium current in AtT-20 cells. Neuroscience 73: 855-864.
22. Millar, R.P. & C.L. Newton 2010. The year in G protein-coupled receptor research. Mol. Endocrinol. 24: 261-274.
23. Kilpatrick, G.J., F.M. Dautzenberg, G.R. Martin & R.M. Eglen 1999. 7TM receptors: the splicing on the cake. Trends Pharmacol. Sci. 20: 294-301.
24. Chen, A.M., M.H. Perrin, M.R. Digruccio, et al 2005. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U.S.A. 102: 2620-2625.
25. Hasegawa, H., M. Negishi & A. Ichikawa 1996. Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J. Biol. Chem. 271: 1857-1860.
26. Neill, J.D., L.C. Musgrove & L.W. Duck 2004. Newly recognized GnRH receptors: function and relative role. Trends Endocrinol. Metab. 15: 383-392.
27. Rekasi, Z., T. Czompoly, A.V. Schally & G. Halmos 2000. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc. Natl. Acad. Sci. U.S.A. 97: 10561-10566.
28. Markovic, D. & R.A. Challiss 2009. Alternative splicing of G protein-coupled receptors: physiology and pathophysiology. Cell Mol. Life Sci. 66: 3337-3352.
29. Vanetti, M., G. Vogt & V. Hollt 1993. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 331: 260-266.
30. Rogers, J. & R. Wall 1980. A mechanism for RNA splicing. Proc. Natl. Acad. Sci. U.S.A. 77: 1877-1879.
31. Duran-Prado, M., M.D. Gahete, A.J. Martinez-Fuentes, et al 2009. Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J. Clin. Endocrinol. Metab. 94: 2634-2643.
32. Cordoba-Chacon, J., M.D. Gahete, M. Duran-Prado, et al 2010. Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell Mol. Life Sci. 67: 1147-1163.
33. Burset, M., I.A. Seledtsov & V.V. Solovyev 2000. Analysis of canonical and noncanonical splice sites in mammalian genomes. Nucleic Acids Res. 28: 4364-4375.
34. Murray, J.I., R.B. Voelker, K.L. Henscheid, et al 2008. Identification of motifs that function in the splicing of noncanonical introns. Genome Biol. 9: R97.
35. Black, D.L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72: 291-336.
36. Smith, D.J., C.C. Query & M.M. Konarska 2008. "Nought may endure but mutability": spliceosome dynamics and the regulation of splicing. Mol. Cell 30: 657-666.
37. Clark, F. & T.A. Thanaraj 2002. Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum. Mol. Genet. 11: 451-464.
38. Olias, G., C. Viollet, H. Kusserow, et al 2004. Regulation and function of somatostatin receptors. J. Neurochem. 89: 1057-1091.
39. Burstein, E.S., T.A. Spalding & M.R. Brann 1998. The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling. J. Biol. Chem. 273: 24322-24327.
40. Gether, U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21: 90-113.
41. Duran-Prado, M., A. Saveanu, R.M. Luque, et al 2010. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs. J. Clin. Endocrinol. Metab. 95: 2497-2502.
42. Gentles, A.J. & S. Karlin 1999. Why are human G-protein-coupled receptors predominantly intronless? Trends Genet. 15: 47-49.
43. Brosius, J. & S.J. Gould 1992. On "genomenclature": a comprehensive (and respectful) taxonomy for pseudogenes and other "junk DNA." Proc. Natl. Acad. Sci. U.S.A. 89: 10706-10710.
44. Brosius, J. 1999. Many G-protein-coupled receptors are encoded by retrogenes. Trends Genet. 15: 304-305.
45. Jordan, I.K., L. Marino-Ramirez, Y.I. Wolf & E.V. Koonin 2004. Conservation and coevolution in the scale-free human gene coexpression network. Mol. Biol. Evol. 21: 2058-2070.
46. Shabalina, S.A., A.Y. Ogurtsov, A.N. Spiridonov, et al 2010. Distinct patterns of expression and evolution of intronless and intron-containing mammalian genes. Mol. Biol. Evol. 27: 1745-1749.
47. Hukovic, N., R. Panetta, U. Kumar, et al 1998. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J. Biol. Chem. 273: 21416-21422.
48. Wente, W., T. Stroh, A. Beaudet, et al 2005. Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. J. Biol. Chem. 280: 32419-32425.
49. Reubi, J.C., B. Waser, Q. Liu, et al 2000. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J. Clin. Endocrinol. Metab. 85: 3882-3891.
50. Stroh, T., P. Sarret, G.S. Tannenbaum & A. Beaudet 2006. Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus. Neurochem. Res. 31: 247-257.
51. Calebiro, D., V.O. Nikolaev, M.C. Gagliani, et al 2009. Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 7: e1000172.
52. Calebiro, D., V.O. Nikolaev, L. Persani & M.J. Lohse 2010. Signaling by internalized G-protein-coupled receptors. Trends Pharmacol. Sci. 31: 221-228.
53. Ferrandon, S., T.N. Feinstein, M. Castro, et al 2009. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 5: 734-742.
54. Mullershausen, F., F. Zecri, C. Cetin, et al 2009. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat. Chem. Biol. 5: 428-434.
55. Claeysen, S., M. Sebben, C. Becamel, et al 1999. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol. Pharmacol. 55: 910-920.
56. Fagni, L., P. Chavis, F. Ango & J. Bockaert 2000. Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci. 23: 80-88.
57. Namba, T., Y. Sugimoto, M. Negishi, et al 1993. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365: 166-170.
58. Akbar, M., F. Okajima, H. Tomura, et al 1994. Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells. FEBS Lett. 348: 192-196.
59. Ben-Shlomo, A., K.A. Wawrowsky, I. Proekt, et al 2005. Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion. J. Biol. Chem. 280: 24011-24021.
60. Carruthers, A.M., A.J. Warner, A.D. Michel, et al 1999. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. Br. J. Pharmacol. 126: 1221-1229.
61. Cervia, D., P. Zizzari, B. Pavan, et al 2003. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology 44: 672-685.
62. Durán-Prado, M., R. Vázquez-Martínez, B.J. González, et al 2005. The growing family of pig somatostatin receptors: novel insights from the cloning of new, truncated sst isoforms. 5° Congreso de la Asociación Ibérica de Endocrinología Comparada (AIEC). Faro Portugal
63. Ishii, Y. & K. Sakamoto 2001. Suppression of protein kinase C signaling by the novel isoform for bovine PGF(2alpha) receptor. Biochem. Biophys. Res. Commun. 285: 1-8.
64. Pawson, A.J., S. Maudsley, K. Morgan, et al 2005. Inhibition of human type i gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment. Endocrinology 146: 2639-2649.
65. Seck, T., M. Pellegrini, A.M. Florea, et al 2005. The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. Mol. Endocrinol. 19: 2132-2144.
66. Bakker, R.A., A.F. Lozada, A. van Marle, et al 2006. Discovery of naturally occurring splice variants of the rat histamine H3 receptor that act as dominant-negative isoforms. Mol. Pharmacol. 69: 1194-1206.
67. Harada, N., Y. Yamada, K. Tsukiyama, et al 2008. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice. Am. J. Physiol. Endocrinol. Metab. 294: E61-E68.
68. Nag, K., N. Sultana, A. Kato & S. Hirose 2007. Headless splice variant acting as dominant negative calcitonin receptor. Biochem. Biophys. Res. Commun. 362: 1037-1043.
69. van Rijn, R.M., A. van Marle, P.L. Chazot, et al 2008. Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor. Biochem. J. 414: 121-131.
70. Sztainberg, Y., Y. Kuperman, O. Issler, et al 2009. A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. Faseb J. 23: 2186-2196.
71. Duran-Prado, M., C. Bucharles, B.J. Gonzalez, et al 2007. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization. Endocrinology 148: 411-421.